Table I.
Differentiation (grade) | Number of cases | FUBP1 mRNA expression relative quantification (gliomas/peri-cancerous tissues) | P-value |
---|---|---|---|
Medium-well differentiated (grade I–II) | 23 | 1.724 ±0.163 | < 0.05* |
Anaplastic glioma (grade III) | 11 | 1.824 ±0.185 | |
Glioblastoma (GBM, grade IV) | 9 | 1.853 ±0.178 |
A one-way ANOVA showed that FUBP1 mRNA expression in brain glioma tissue was significantly different among the three groups with different pathological differentiation of glioma (p < 0.05). The LSD test showed significant difference between groups of medium-well differentiated glioma (grade I–II) and anaplastic glioma (grade: III) (p = 0.03), as well as groups of medium-well differentiated glioma (grade I–II) and glioblastoma (GBM, grade: IV) (p = 0.01).